Krystal Biotech, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Krystal Biotech, Inc. reported Cash And Cash Equivalents At Carrying Value of $496.30 million for the year ending 2025.

  • Krystal Biotech, Inc. showed an increase of +43.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Krystal Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), Krystal Biotech, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 25,708.8%.
  • Historical annual values: Fiscal year 2025: $496.30 million | Fiscal year 2024: $344.87 million | Fiscal year 2023: $358.33 million | Fiscal year 2022: $161.90 million | Fiscal year 2021: $341.25 million | Fiscal year 2020: $268.27 million | Fiscal year 2019: $187.51 million | Fiscal year 2018: $103.67 million | Fiscal year 2017: $49.59 million | Fiscal year 2016: $1.92 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: